Acylcarnitine is released from abnormal mitochondria in peripheral glial cells to affect surrounding axons, resulting in the destruction of axonal membrane properties and the induction of axonal degeneration, which has been shown to be neurotoxic [116]
When FDA asks whether something should be a permissible bulk substance for compounding, the agency isnt adjudicating internet testimonials
Every so often, a medical topic escapes the clinic and takes over everything: office visits, lunch conversations, weekend coffee, and my inbox
No big RCTs evaluate BPC-157 for fertility outcomes, such as conception, live birth, or enhanced ovarian reserve
These side effects are documented in clinical trials and patient reports
There is no verification of start and stop dates of the medication